Wheezy lungs in the sneezy seasons of life: Asthma risk factors, immunomodulation and inflammatory dynamics

Geertje M. de Boer

Research output: Types of ThesisDoctoral ThesisInternal

117 Downloads (Pure)

Abstract

Standard medical interventions, such as lifestyle interventions, inhaled medication and antihistamines, are not sufficient in approximately 5% of asthma patients; their asthma is defined as ‘severe asthma'.
Treatment options in those patients also consist of suppression of specific immunological pathways aimed at type 2 inflammation by monoclonal antibodies or “biologicals”. Despite the availability of these treatment options, some patients will still not reach adequate
asthma control.
This is currently an unmet need that might result in overtreatment. In the past years, treatment of asthma has developed towards a more personalized approach taking the T2 status into account. This thesis comprises studies on risk factors for the
development of asthma later in life and the effects of time and exacerbations on persistence and nature of asthma inflammation. Also, immunomodulation with bacterial lysates is being described, to prevent asthma exacerbations in children and adults, with uncontrolled asthma and recurrent exacerbations.
Original languageEnglish
Awarding Institution
  • Erasmus University Rotterdam
Supervisors/Advisors
  • Hendriks, Rudi, Supervisor
  • Braunstahl, Gert-Jan, Co-supervisor
  • Tramper, Gerdien, Co-supervisor
Award date30 Nov 2023
Place of PublicationRotterdam
Publication statusPublished - 30 Nov 2023

Fingerprint

Dive into the research topics of 'Wheezy lungs in the sneezy seasons of life: Asthma risk factors, immunomodulation and inflammatory dynamics'. Together they form a unique fingerprint.

Cite this